Being immunocompromised increases risk of rare Mycobacterium tuberculosis epididymo-orchitis.
Antibiotics are the mainstay treatment for CAP; however, the additive role of corticosteroids is continually being debated.
Expanding the differential for diarrhea beyond Clostridium difficile.
SMUCLA implements high-touch wipe down intervention to address the need for environmental disinfection of cancer patient care areas.
A commentary on β-lactam combination therapy for methicillin-resistant Staphylococcus aureus bacteremia.
While rising temperatures and sea levels are often considered, changing climate patterns can have vast implications for epidemic risk as well.
A death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.
Outcomes in disseminated nocardiosis are variable and depend on patient factors.
New public health perspectives on aspergillosis, sporotrichosis, histoplasmosis, and coccidioidomycosis.
A review of the current literature and future directions.
It can help inform appropriate antibiotic prescribing, but likely would only form part of testing protocol, experts say.
With advancements in antiretroviral therapy, people with HIV are now living longer and developing age-related chronic conditions.
A patient with HIV and skin lesions should trigger a broad differential.
Rising incidence of viral and bacterial infections has accompanied the opioid crisis, but it also presents new opportunities for multidisciplinary treatment and preventive care.
While antibiotics serve a meaningful purpose in treating infections, appropriate use of these agents is needed in order to minimize adverse events.
This article seeks to review newer ART agents, as well as those in later stages of drug development, for the treatment of HIV-1 infection.
As researchers discover Chikungunya-carrying mosquitoes in Brazil, a new study analyzes the impact of the Zika virus on the area.
Use of an IL-6 inhibitor has the potential to prevent the cytokine storm caused by severe COVID-19 infection.
As a growing number of infections become resistant to antibiotic medications, it is becoming crucially important that providers not only practice antibiotic stewardship but also use effective antibiotics when they are needed.
New public health perspectives on aspergillosis, sporotrichosis, histoplasmosis, and coccidioidomycosis.
How has treating infections changed with the availability of experimental vaccines and therapeutics, and how can we apply this to COVID-19 today?
A rare metallo-ß-lactamase makes its way into the United States via an 84-year-old patient.
One successful model takes an engineering approach to patient safety outcomes focusing on work system improvements.
A recent study published in Transgender Health analyzed transgender and gender-nonconforming ART adherence based on the US Trans Survey, the largest survey of TGNC people in the United States.
Taking into account the severity of this flu season, it is important that health care providers understand and choose the best treatment option for each patient.
An examination of broad-spectrum antibiotic use in this patient population is essential for developing strategies to mitigate the risk of these infections.
In this narrative review of studies evaluating antiretroviral stewardship programs (ARVSPs), we propose core elements for ARVSPs that are based on published evidence, clinical experience, and adapted from antimicrobial stewardship programs.